BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16482673)

  • 1. Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.
    Killen JP
    N Engl J Med; 2006 Feb; 354(7):764-5; author reply 764-5. PubMed ID: 16482673
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.
    Karassa FB
    N Engl J Med; 2006 Feb; 354(7):764-5; author reply 764-5. PubMed ID: 16481648
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil for lupus nephritis.
    McCune WJ
    N Engl J Med; 2005 Nov; 353(21):2282-4. PubMed ID: 16306526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mycophenolate mofetil in lupus nephritis treatment].
    Savio V; Alba P; Babini AM
    Rev Fac Cien Med Univ Nac Cordoba; 2012; 69(4):219-23. PubMed ID: 23751789
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.
    Karassa FB; Isenberg DA
    N Engl J Med; 2001 Feb; 344(5):382-3. PubMed ID: 11195799
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
    N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
    Burchardi C; Schlöndorff D
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
    [No Abstract]   [Full Text] [Related]  

  • 9. [Response to mycophenolate mofetil in a case of lupus nephropathy resistant to cyclophosphamide IV and cyclosporin A].
    Navas-Parejo A; Espigares MJ; Alhosni A; García-Valdecasas J
    Nefrologia; 2001; 21(5):516-7. PubMed ID: 11795027
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.
    Elliott JR; Manzi S
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):354-5. PubMed ID: 16932717
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil for treatment of refractory lupus nephritis.
    Johnson DW
    Intern Med J; 2001 Jul; 31(5):312. PubMed ID: 11512604
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mycophenolate mofetil for lupus nephritis refractory to cyclophosphamide].
    Baños I; Yebra M; Fernández J; Ramón y Cajal S
    Med Clin (Barc); 2003 Jun; 121(4):158. PubMed ID: 12867023
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.
    Glicklich D; Acharya A
    Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine.
    Fu YF; Liu GL
    Clin Nephrol; 2001 Apr; 55(4):318-21. PubMed ID: 11334319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil in lupus nephritis.
    Ginzler EM; Aranow C
    Lupus; 2005; 14(1):59-64. PubMed ID: 15732290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
    Ginzler EM; Wofsy D; Isenberg D; Gordon C; Lisk L; Dooley MA;
    Arthritis Rheum; 2010 Jan; 62(1):211-21. PubMed ID: 20039429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclosporine A in treatment of lupus nephritis resistant to cyclophosphamide and mycophenolate mofetil: a case report].
    Mellor-Pita S; Yebra Bango M; Tutor-Ureta P; Fernández J
    Rev Clin Esp; 2006 Oct; 206(9):464-5. PubMed ID: 17042994
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.
    Lau KK; Ault BH; Jones DP; Butani L
    J Pediatr Health Care; 2008; 22(5):282-8. PubMed ID: 18761229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological therapy of lupus nephritis.
    Fine DM
    JAMA; 2005 Jun; 293(24):3053-60. PubMed ID: 15972568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephroquiz 1: cyclophosphamide or mycofenolate mofetil?
    Samadian F; Parvin M; Faraji A; Ahmadpoor P
    Iran J Kidney Dis; 2009 Apr; 3(2):112-3. PubMed ID: 19395789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.